Publications

Export 3694 results:
Sort by: [ Author  (Desc)] Title Type Year
A B C D E [F] G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
F
Fouda, M. E., A. Soltan, A. G. Radwan, and A. M. Soliman, "Fractional-order multi-phase oscillators design and analysis suitable for higher-order PSK applications", Analog Integrated Circuits and Signal Processing, vol. 87, no. 2: Springer US, pp. 301–312, 2016. Abstract
n/a
Fouda, M. E., A. G. Radwan, and A. Elwakil, "Memristor and Inverse Memristor: Modeling, Implementation and Experiments", Advances in Memristors, Memristive Devices and Systems: Springer, Cham, pp. 371–392, 2017. Abstract
n/a
Fouda, R., H. Ammar, E. Sobhy, and A. M. Amin, "Unusual cause of pericardial effusion", BMJ Case Reports, vol. 2012, 2012. AbstractWebsite

A 65-year-old Egyptian lady suffering from non-alcoholic liver cirrhosis was referred to our unit for evaluation of a massive pericardial effusion. Few weeks before presentation, she suffered from progressive abdominal distention and dyspnoea. She denied fever, rigors or other cardiorespiratory symptoms. Examination revealed shrunken liver, spleenomegaly and ascites. Chest was clear to auscultation and heart sounds were distant. Chest radiograph showed cardiomegaly and clear lung fields. Abdominal ultrasound confirmed the results of abdominal examination. Transthoracic echocardiogram (TTE) revealed a massive pericardial effusion (PEF) and rheumatic mitral stenosis. Chest tomography showed PEF and clear lung fields. One litre of exudate was removed via TTE-guided needle pericardiocentesis. A pericardio-peritoneal shunt was suspected, which was confirmed via a radioisotopic study. This case is among very few cases that reported PEF in a cirrhotic ascetic patient secondary to a radio-isotopically confirmed pericardio-peritoneal shunt in the literature.

Fouda, M. E., M. A. Khatib, A. G. Mosad, and A. G. Radwan, "Generalized Analysis of Symmetric and Asymmetric Memristive Two-Gate Relaxation Oscillators", IEEE Tcas I, no. 99: IEEE, pp. 1–8, 2013. Abstract
n/a
Fouda, K. Z., A. A. Abdel-aziem, and W. T. Mansour, "Effect of Frequency Modulation versus Pulse Duration Modulation of Electrical Stimulation on Muscle Torque and Discomfort in Patients with Stroke", International Journal of Therapies and Rehabilitation Research, vol. 6, issue 1, pp. 148-155, 2017. ijtrr-2017-paper.pdf
Fouda, M. E., and A. G. Radwan, "Boundary Dynamics of Memcapacitor in Voltage-Excited Circuits and Relaxation Oscillators", Circuits, Systems, and Signal Processing, vol. 34, no. 9: Springer US, pp. 2765–2783, 2015. Abstract
n/a
Fouda, U. M., A. M. Sayed, D. I. Ramadan, and I. M. Fouda, "Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.", Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, vol. 30, issue 8, pp. 842-6, 2010. Abstract

The aim of this randomised controlled trial was to compare efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome. A total of 60 women with a minimum of three consecutive abortions before 10 weeks' gestation and positive lupus anticoagulant and/or anticardiolipin antibodies on at least two occasions at least 12 weeks apart were randomised into two groups based on computer generated randomisation list concealed in opaque envelopes. Pregnant women were treated with enoxaparin 40 mg plus low dose aspirin (LDA) (n = 30) or enoxaparin 20 mg plus LDA (n = 30). The live birth rate was 76.67% in enoxaparin 40 mg group and 70% in enoxaparin 20 mg group (p value = 0.559). There were no significant differences between both groups with respect to neonatal outcome, obstetric and maternal complications during pregnancy or puerperium. No cases of severe bleeding, thrombocytopenia or spontaneous fractures were reported in both groups.

Fouda, K. Z., "Effect of Low Energy versus Medium Energy Radial Shock Wave Therapy in The Treatment of Chronic Planter Fasciitis", International Journal of Physiotherapy , vol. 3, issue 1, pp. 5-10, 2016. final_article_2016.pdf
Fouda, M. E., and A. G. Radwan, "Fractional-order memristor response under dc and periodic signals", Circuits, Systems, and Signal Processing, vol. 34, no. 3: Springer US, pp. 961–970, 2015. Abstract
n/a
Fouda, M. E., A. S. Elwakil, and A. Allagui, "Commercial supercapacitor parameter estimation from step voltage excitation", International Journal of Circuit Theory and Applications, vol. 47, no. 10, pp. 1705–1712, 2019. Abstract
n/a
Fouda, M. E., A. G. Radwan, and A. Elwakil, "Memristor and Inverse Memristor: Modeling, Implementation and Experiments", Advances in Memristors, Memristive Devices and Systems: Springer International Publishing, pp. 371–392, 2017. Abstract
n/a
Fouda, M. E., A. G. Radwan, and A. S. Elwakil, "Series and parallel circuit models containing memristors and inverse memristors", Electronics, Circuits, and Systems (ICECS), 2015 IEEE International Conference on: IEEE, pp. 292–295, 2015. Abstract
n/a
Fouda, A. Y., A. S. Newsome, S. Spellicy, J. L. Waller, W. Zhi, D. C. Hess, A. Ergul, D. J. Edwards, S. C. Fagan, and J. A. Switzer, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial.", Stroke, vol. 48, issue 10, pp. 2885-2887, 2017 10. Abstract

BACKGROUND AND PURPOSE: Minocycline is under investigation as a neurovascular protective agent for stroke. This study evaluated the pharmacokinetic, anti-inflammatory, and safety profile of minocycline after intracerebral hemorrhage.

METHODS: This study was a single-site, randomized controlled trial of minocycline conducted from 2013 to 2016. Adults ≥18 years with primary intracerebral hemorrhage who could have study drug administered within 24 hours of onset were included. Patients received 400 mg of intravenous minocycline, followed by 400 mg minocycline oral daily for 4 days. Serum concentrations of minocycline after the last oral dose and biomarkers were sampled to determine the peak concentration, half-life, and anti-inflammatory profile.

RESULTS: A total of 16 consecutive eligible patients were enrolled, with 8 randomized to minocycline. Although the literature supports a time to peak concentration (T) of 1 hour for oral minocycline, the T was estimated to be at least 6 hours in this cohort. The elimination half-life (available on 7 patients) was 17.5 hours (SD±3.5). No differences were observed in inflammatory biomarkers, hematoma volume, or perihematomal edema. Concentrations remained at neuroprotective levels (>3 mg/L) throughout the dosing interval in 5 of 7 patients.

CONCLUSIONS: In intracerebral hemorrhage, a 400 mg dose of minocycline was safe and achieved neuroprotective serum concentrations. However, oral administration led to delayed absorption in these critically ill patients and should not be used when rapid, high concentrations are desired. Given the safety and pharmacokinetic profile of minocycline in intracerebral hemorrhage and promising data in the treatment of ischemic stroke, intravenous minocycline is an excellent candidate for a prehospital treatment trial.

CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01805895.

Fouda, R., H. Ammar, E. Sobhy, and A. M. Amin, "Unusual cause of pericardial effusion.", BMJ case reports, vol. 2012, 2012. Abstract

A 65-year-old Egyptian lady suffering from non-alcoholic liver cirrhosis was referred to our unit for evaluation of a massive pericardial effusion. Few weeks before presentation, she suffered from progressive abdominal distention and dyspnoea. She denied fever, rigors or other cardiorespiratory symptoms. Examination revealed shrunken liver, spleenomegaly and ascites. Chest was clear to auscultation and heart sounds were distant. Chest radiograph showed cardiomegaly and clear lung fields. Abdominal ultrasound confirmed the results of abdominal examination. Transthoracic echocardiogram (TTE) revealed a massive pericardial effusion (PEF) and rheumatic mitral stenosis. Chest tomography showed PEF and clear lung fields. One litre of exudate was removed via TTE-guided needle pericardiocentesis. A pericardio-peritoneal shunt was suspected, which was confirmed via a radioisotopic study. This case is among very few cases that reported PEF in a cirrhotic ascetic patient secondary to a radio-isotopically confirmed pericardio-peritoneal shunt in the literature.

Fouda, M. A., R. M. Allam, F. M. Moftah, and R. A. M. El-Fetouh, "The Role of ID-NAT in Enhancing Blood Safety at the Egyptian National Cancer Institute - A 5 Year Experience", Journal of the Egyptian Society of Haematology & Research, vol. 14, issue 2, pp. 1-6, 2018.
Fouda, U. M., and A. M. Sayed, "Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET.", Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, vol. 27, issue 12, pp. 1018-22, 2011 Dec. Abstract

OBJECTIVE: To compare the efficacy and cost-effectiveness of extended high dose letrozole regimen/HPuFSH-gonadotropin releasing hormone antagonist (GnRHant) protocol with short low dose letrozole regimen/HPuFSH-GnRHant protocol in poor responders undergoing IVF-ET.

METHODS: In this randomized controlled trial, 136 women who responded poorly to GnRH agonist long protocol in their first IVF cycle were randomized into two equal groups using computer generated list and were treated in the second IVF cycle by either extended letrozole regimen (5 mg/day during the first 5 days of cycle and 2.5 mg/day during the subsequent 3 days) combined with HPuFSH-GnRHant protocol or short letrozole regimen (2.5 mg/day from cycle day 3-7) combined with HPuFSH-GnRHant protocol.

RESULTS: There were no significant differences between both groups with regard to number of oocytes retrieved and clinical pregnancy rate (5.39 ± 2.08 vs. 5.20 ± 1.88 and 22.06% vs. 16.18%, respectively).The total gonadotropins dose and medications cost per cycle were significantly lower in extended letrozole group (44.87 ± 9.16 vs. 59.97 ± 14.91 ampoules and 616.52 ± 94.97 vs. 746.84 ± 149.21 US Dollars ($), respectively).The cost-effectiveness ratio was 2794 $ in extended letrozole group and 4616 $ in short letrozole group.

CONCLUSION: Extended letrozole regimen/HPuFSH-GnRHant protocol was more cost-effective than short letrozole regimen/HPuFSH-GnRHant protocol in poor responders undergoing IVF-ET.

Fouda, A. S., K. H. Attia, A. M. Abouelezz, M. A. El-Ghafour, and M. H. Aboulfotouh, "Anchorage control using miniscrews in comparison to Essix appliance in treatment of postpubertal patients with Class II malocclusion using Carrière Motion Appliance.", The Angle Orthodontist, 2021. Abstract
n/a
Fouda, M. E., M. A. Khatib, and A. G. Radwan, "On the mathematical modeling of series and parallel memcapacitors", Microelectronics (ICM), 2013 25th International Conference on: IEEE, pp. 1–4, 2013. Abstract
n/a
Fouda, M. E., A. AboBakr, A. S. Elwakil, A. G. Radwan, and A. M. Eltawil, "Simple MOS Transistor-Based Realization of Fractional-Order Capacitors", 2019 IEEE International Symposium on Circuits and Systems (ISCAS): IEEE, pp. 1–4, 2019. Abstract
n/a
Fouda, A. S., M. H. AboulFotouh, K. H. Attia, and A. M. Aboulezezz, "Carriere Motion Appliance with Miniscrew Anchorage for Treatment of Class II, Division 1 Malocclusion", Journal of clinical orthodontics: JCO, vol. 54, issue 10, pp. 633-641, 2020. Abstract
n/a